Issue 27, 2021, Issue in Progress

Retraction: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway

Abstract

Retraction of ‘Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway’ by Dingmei Deng et al., RSC Adv., 2019, 9, 20385–20394, DOI: 10.1039/C9RA00016J.

Associated articles

Article information

Article type
Retraction
Submitted
26 Apr 2021
Accepted
26 Apr 2021
First published
05 May 2021
This article is Open Access
Creative Commons BY license

RSC Adv., 2021,11, 16478-16478

Retraction: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway

L. Fisher, RSC Adv., 2021, 11, 16478 DOI: 10.1039/D1RA90114A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements